---
title: "LifeMD, Inc. (LFMD.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/LFMD.US.md"
symbol: "LFMD.US"
name: "LifeMD, Inc."
industry: "Health Care Technology"
datetime: "2026-05-20T17:03:36.229Z"
locales:
  - [en](https://longbridge.com/en/quote/LFMD.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LFMD.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LFMD.US.md)
---

# LifeMD, Inc. (LFMD.US)

## Company Overview

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men’s telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men’s health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more.

| Item | Detail |
|------|--------|
| Industry | Health Care Technology |
| Exchange | US Market |
| Website | [lifemd.com](https://lifemd.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: B (0.39)**

**Industry**: Health Care Technology

| Metric | Value |
|--------|-------|
| Industry Ranking | 8 / 47 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 19.66% |  |
| Net Profit YoY | 114.27% |  |
| P/B Ratio | 13.83 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 207958793.00 |  |
| Revenue | 193330255.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -335.22% | E |
| Profit Margin | 2.93% | C |
| Gross Margin | 88.19% | A |
| Revenue YoY | 19.66% | B |
| Net Profit YoY | 114.27% | A |
| Total Assets YoY | -4.74% | D |
| Net Assets YoY | 3928.57% | A |
| Cash Flow Margin | 316.45% | A |
| OCF YoY | 19.66% | B |
| Turnover | 2.69 | A |
| Gearing Ratio | 78.56% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - LifeMD, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "19.66%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "114.27%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "13.83",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "207958793.00",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "193330255.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "-335.22%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "2.93%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "88.19%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "19.66%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "114.27%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-4.74%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "3928.57%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "316.45%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "19.66%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "2.69",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "78.56%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 81.26 | 9/47 | 21.88 | 17.44 | 15.87 |
| PB | 13.83 | 31/47 | 132.96 | 108.05 | 8.51 |
| PS (TTM) | 1.08 | 13/47 | 2.01 | 1.12 | 0.69 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | QHSLab, Inc. (USAQ.US) | A | A | A | A | C | A |
| 02 | Veeva Systems -CL (VEEV.US) | A | B | C | A | B | B |
| 03 | Waystar (WAY.US) | B | A | D | B | B | B |
| 04 | Doximity (DOCS.US) | A | C | C | A | B | B |
| 05 | HeartFlow (HTFL.US) | B | A | B | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-14T04:00:00.000Z

Total Analysts: **8**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 8 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 4.32 |
| Highest Target | 15.00 |
| Lowest Target | 8.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/LFMD.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/LFMD.US/norm.md)
- [Related News](https://longbridge.com/en/quote/LFMD.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/LFMD.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**